Legend:
CC = Vancouver Convention Centre
F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
37 !
Sun, 7/29/2018,
2:00 PM -
3:50 PM
CC-West 304/305
Statistical Issues Specific the Therapeutic Areas - 1 — Contributed Papers
Biopharmaceutical Section
Chair(s): Hui Wang, Amgen, Inc.
2:05 PM
Robust Dose Response Estimation
Shouhao Zhou, University of Texas MD Anderson Cancer Center
2:20 PM
Statistical Development in Addressing Delayed Treatment Effect or Crossing Survival Curves in Immuno-Oncology Clinical Trials
Huyuan Yang, Takeda Oncology Pharmaceutical
2:35 PM
Cure Survival Data in Oncology Studies
Shih-Yuan Lee, Takeda
2:50 PM
Meta-Analysis for the Adjuvant Treatment in Renal Cell Carcinoma
Weichao Bao, Novartis Pharmaceuticals Corporation
3:05 PM
Correlation Between the Time-To-Event Endpoints in Prostate Cancer Clinical Trials
Susan Li, Janssen R&D
3:20 PM
Statistical Evaluation of Oncology Drug Trial Portfolios and the Potential for Inappropriate Regulatory Approval: a Simulation Study
Renee Gennarelli, Memorial Sloan Kettering Cancer Center ; Peter Bach, Memorial Sloan Kettering Cancer Center; Mithat Gonen, Memorial Sloan Kettering Cancer Center
3:35 PM
A Case Study on Model Based Meta-Analysis (MBMA) for Drug Development Decisions
Guohui Liu, Takeda Pharmaceuticals Inc ; Zhaoyang Teng, Takeda pharmaceuticals international, Co; Zhaowei Hua, Takeda Pharmaceuticals International Co.; Neeraj Gupta, Takeda pharmaceuticals international, Co; Richard Labotka, Takeda pharmaceuticals international, Co
